Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on stopped working epilepsy medication, boasts FDA operate

.Our experts currently understand that Takeda is intending to locate a course to the FDA for epileps...

VBI Vaccines files for bankruptcy, finds resource purchase

.Immunology biotech VBI Injections is actually diverting dangerously near the point of no return, al...

Celldex anti-cKIT antibody reduce hives in yet another period 2 research

.It's not easy to muscular tissue in on a room as affordable as immunology, but Celldex Therapies st...

Boehringer provides to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapeutics and a preclinical invulner...

Ventyx's last hope for inflamed med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's ailment medicine did certainly not help patients obtain remission in a ...

Cognition's period 2 radiate information tarnish Alzheimer's possibility

.Knowledge Therapies' period 2 SHINE trial has taken a few of the gloss off the Alzheimer's health c...

BMS axes bispecific months after submitting to work phase 3 test

.Bristol Myers Squibb has had a whiplash change of heart on its BCMA bispecific T-cell engager, stop...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., that supervised Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers S...

Asarina to shut after initiatives to companion Tourette's drug fall short

.After connecting to greater than 200 companies to companion a Tourette disorder therapy that reveal...